4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Beijing Chunlizhengda Medical Instruments Co., Ltd. (1858) operates in the Medical Devices industry and is headquartered in Beijing, China with about 1,078 employees. Its market capitalization is roughly CNY 4 billion. In the fiscal year ended 2025-12-31, 1858 reported CNY 1.0B in revenue and CNY 272M in net income.
Beijing Chunlizhengda Medical Instruments Co., Ltd., together with its subsidiaries, engages in the research, development, production, and sale of surgical implants, instruments, and related products in the People's Republic of China and internationally.
Interactive charts & full statements →
| Income statement | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Revenue | CNY 1.0B | CNY 806M | CNY 1.2B | CNY 1.2B | — |
| Gross Profit | CNY 691M | CNY 537M | CNY 876M | CNY 914M | — |
| Operating Income (EBIT) | CNY 323M | CNY 132M | CNY 293M | CNY 333M | — |
| Net Income | CNY 272M | CNY 125M | CNY 278M | CNY 308M | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Dividends Paid | (CNY 19M) | (CNY 170M) | (CNY 120M) | (CNY 50M) | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Total Assets | CNY 3.7B | CNY 3.5B | CNY 3.6B | CNY 3.4B | — |
| Total Liabilities | CNY 674M | CNY 644M | CNY 770M | CNY 690M | — |
CNY; CNYM / CNYB as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive 1858 viewer.
About TickerBase · Data methodology & sources · Privacy · Terms